Medicine and Dentistry
Patient
100%
Rheumatoid Arthritis
96%
G Protein Coupled Receptor
68%
Tumor Necrosis Factor
62%
Inpatient
51%
Population Research
48%
Mortality
46%
Systemic Scleroderma
41%
Gout
41%
Inflammatory Disorder
39%
Hazard Ratio
38%
Rituximab
35%
Monocyte
31%
Urticaria
31%
Incidence
31%
Systemic Lupus Erythematosus
31%
Nephropathy
30%
Woman
29%
Signal Transduction
28%
Malignant Neoplasm
27%
Mitogen-Activated Protein Kinase
27%
Biological Product
26%
Stimulation
24%
Health
24%
Man
23%
Apoplexy
23%
Cardiovascular System
23%
Death
23%
Uric Acid
22%
Male
22%
Environmental Factor
20%
Family
20%
Retrospective Cohort Study
20%
Urate
20%
Virus Reactivation
20%
Urate Crystal
20%
Differentiation
20%
Cohort Analysis
20%
Arthritis
20%
Ventricular Hypertrophy
20%
Spontaneous Remission
20%
Intercellular Adhesion Molecule 1
20%
TNF Inhibitor
20%
Cohort Effect
20%
Heritability
20%
Serositis
20%
Immune Disorder
20%
Hepatitis C Virus
20%
Hyperuricemia
20%
Pathogenesis
20%
Immunology and Microbiology
Inflammatory Arthritis
71%
Cells
48%
Adhesion
44%
Lupus Erythematosus
41%
Regulatory T Cell
41%
Adhesion G Protein-Coupled Receptors
32%
Mouse
31%
Monocyte
27%
Signal Transduction
26%
Systemic Lupus Erythematosus
25%
Myeloid
25%
Human Cytomegalovirus
23%
Rituximab
20%
Adoptive Immunity
20%
Virus Reactivation
20%
Hepatitis C Virus
20%
Bagg Albino Mouse
20%
DNA Methylation
20%
Promoter Region
20%
Macrophage Differentiation
20%
Feces microflora
20%
Autoimmunity
20%
Tumor Necrosis Factor Alpha
20%
CD4
20%
Autoantibodies
20%
Rheumatoid Factor
20%
Modulation
20%
Differentiation
13%
Inflammatory Disorder
13%
Monoclonal Antibodies
11%
Immune System
10%
Amino Terminal Sequence
9%
Immunocompetent Cell
9%
Host
9%
Intravenous Immunoglobulin
9%
Immune Response
9%
Intestine Flora
8%
ELISA
8%
Indoleamine 2,3-dioxygenase
8%
Monospecific Antibody
8%
B Cell
7%
Health
7%
Immunity
7%
Ankylosing Spondylitis
7%
Animal
7%
Normal Human
7%
Mast Cell
6%
Cell Activation
6%
Vibration
6%
Inflammation
6%
Nursing and Health Professions
Gout
62%
Mortality
41%
Incidence
26%
Confidence Interval
24%
Hazard Ratio
20%
Autism
20%
Death
20%
Systemic Lupus Erythematosus
20%
Nonalcoholic Fatty Liver
20%
Epidemiology
20%
Rheumatoid Arthritis
20%
Cohort Analysis
20%
Control
15%
Diagnosis
13%
Standardized Mortality Ratio
12%
Kidney Disease
9%
Cardiovascular Disease
9%
Brain Hemorrhage
7%
Brain Ischemia
7%
National Health Insurance
7%
Endocrine Disease
6%
Metabolic Disorder
6%
Cause of Death
6%
Uric Acid Blood Level
6%
Prevalence
6%
Population
6%
Proportional Hazards Model
5%
Malignant Neoplasm
5%
All Cause Mortality
5%
End Stage Renal Disease
5%